The landscape of dementia diagnosis has evolved significantly with the appearance of refined biomarkers, which include amyloid PET scans, tau imaging, and blood-based tests that may detect Alzheimer's pathology several years in advance of signs emerge. Though these technological innovations characterize impressive progress in understanding neurodegenerative health conditions, they have https://timd197blv6.blogthisbiz.com/profile